In India, traditional systems of medicine such as Ayurveda have played a very significant role in the mitigation of COVID-19. AYUSH-64 was one of the main Ayurveda formulations which were used for the management of asymptomatic, mild, and moderate cases of COVID-19. To serve as a resource for future research, we set out to analyze the research articles on AYUSH-64 for COVID-19. In this study, the publications from the year 2019 to 2024, related to AYUSH-64, were searched in the Dimensions database and bibliometrically analyzed with VOSviewer 1.6.19 software. A total of 34 publications were found from 22 journals and 3 preprint platform sources. Chief contribution from 64 authors and 17 organizations was identified, and 17 keywords were used more than 10 times indicating clinical research as the hotspot for AYUSH-64. Overall, this analysis suggests the presence of a limited yet substantial number of good-quality research publications associated with AYUSH-64 for COVID-19. Furthermore, the study highlights the notable level of research collaboration, as evidenced by the strong associations among highly contributing authors.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: